Last reviewed · How we verify
NCT03661736: PLATYPUS
Growth of Infants With Cow's Milk Allergy Fed an Amino Acid-based Formula Containing Two Human Milk Oligosaccharides
trial testing Food for Specific Medical Purpose in Cow Milk Allergy in 33 participants. Completed in 30 October 2020.
30 October 2020
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 33 |
| Start date | 12 April 2018 |
| Primary completion | 30 October 2020 |
| Estimated completion | 30 October 2020 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Food for Specific Medical Purpose
Conditions studied
- Cow Milk Allergy — all drugs for Cow Milk Allergy →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
Adults 1 Month to 8 Months, any sex, with Cow Milk Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this study is to provide longitudinal growth data in infants with moderate-to-severe cow's milk allergy fed an amino acid-based formula with two added human milk oligosaccharides.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effects of an Amino Acid-Based Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety, and Gut Microbiome in Infants with Cow's Milk Protein Allergy.
Gold MS, Quinn PJ, Campbell DE, Peake J, et al · · 2022 · cited 19× · PMID 35684099 · DOI 10.3390/nu14112297 -
Human Milk Oligosaccharides: Decoding Their Structural Variability, Health Benefits, and the Evolution of Infant Nutrition.
Duman H, Bechelany M, Karav S. · · 2024 · cited 18× · PMID 39796552 · DOI 10.3390/nu17010118
Verify or expand the search:
- PubMed search for NCT03661736
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cow Milk Allergy
Currently open trials in the same condition.
- NCT06380673 — Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy · NA · recruiting
- NCT05785299 — Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy · NA · recruiting
- NCT04249973 — Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children · active not recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03661736 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 21 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03661736.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing